Search
for
Sort by
Research 721–750 of 1000+
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- Current understanding and treatment of sex hormone-related hair diseases
- The effect of melatonin implants administered from December until April, on plasma prolactin, triiodothyronine and thyroxine concentrations and on the timing of the spring moult in cashmere goats
- Ginseng in Hair Growth and Viability
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- The clock gene brain and muscle Arnt-like protein-1 (BMAL1) is involved in hair growth
- Clinical applications of antiandrogens
- Therapeutic options in the polycystic ovary syndrome
- Plants as potential active components in treatment of androgenetic alopecia
- Treatment guidelines in adult women
- Hormonal Therapy for Acne
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- QSAR Analysis of a Series of Hydantoin‐based Androgen Receptor Modulators and Corresponding Binding Affinities
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Pharmacology of antiandrogens
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Steroid Hormones of Reproduction and Sexual Development
- Hormone therapy in acne
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Is dehydroepiandrosterone a hormone?
- Treatment of Hirsutism With Spironolactone
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Dermatology of androgen-related disorders
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Anabolic-androgenic steroids and cardiovascular risk
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- Pharmacologic Therapy of Polycystic Ovary Syndrome